Minerva Neurosciences to Report First Quarter 2020 Financial Results and Business Updates on May 4, 2020
WALTHAM, Mass., April 27, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the […]